Presentation TCT 2025 TCT 766: Protamine At Reduced Dose For TAVR Anticoagulation Reversal Presenter: Mohammed Ebrahim October 27, 2025 REGISTER for free or LOG IN to view this content TCT 2025 Up Next Presentation TCT 2025 TCT 1156: Comparison of 30-Day Readmission Outcomes Following Transcatheter Aortic Valve Replacement in Patients Aged <65 Versus ≥65 Years: Insights from a National Readmission Database Presenter: Junaid Mir October 27, 2025 More slides + Presentation TCT 2025 TCT 1153: Determining Cut-off Values of Non-dimensional Aortic Valve Coefficient (AVC) for Functional Assessment of Aortic Stenosis in TAVR Patients: A Prospective Analysis Presenter: Shreyash Manegaonkar October 27, 2025 Presentation TCT 2025 TCT 770: Clinical Outcomes of Combined RAAS Inhibitor and Statin Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large-Scale Propensity-Matched Analysis Presenter: Amer Hussein Muhyieddeen October 27, 2025 We Recommend Disclosures <p>Nothing to disclose</p>
Presentation TCT 2025 TCT 1156: Comparison of 30-Day Readmission Outcomes Following Transcatheter Aortic Valve Replacement in Patients Aged <65 Versus ≥65 Years: Insights from a National Readmission Database Presenter: Junaid Mir October 27, 2025
Presentation TCT 2025 TCT 1153: Determining Cut-off Values of Non-dimensional Aortic Valve Coefficient (AVC) for Functional Assessment of Aortic Stenosis in TAVR Patients: A Prospective Analysis Presenter: Shreyash Manegaonkar October 27, 2025
Presentation TCT 2025 TCT 770: Clinical Outcomes of Combined RAAS Inhibitor and Statin Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large-Scale Propensity-Matched Analysis Presenter: Amer Hussein Muhyieddeen October 27, 2025